Home / Funds / Citadel Securities (Europe) Limited
Citadel Securities (Europe) Limited
The short positions this fund discloses today, across every market.
15 open positions
5 Markets
September 24, 2026 Last disclosure
549300WTVI4KO4GEJN54 LEI
| Issuer | Market | % of capital | Since |
|---|---|---|---|
| Alzinova AB | Sweden | 0.79% | September 18, 2026 |
| Envipco Holding N.V. | Norway | 0.79% | September 24, 2026 |
| Nordic Mining | Norway | 0.79% | September 24, 2026 |
| Drone Volt | France | 0.76% | September 16, 2026 |
| SynAct Pharma AB | Sweden | 0.72% | August 19, 2026 |
| Tobii AB | Sweden | 0.72% | September 4, 2026 |
| SMAG Mobile Antenna Masts AG | Germany | 0.69% | September 22, 2026 |
| Circio Holding ASA | Norway | 0.64% | September 24, 2026 |
| Aton | France | 0.63% | September 22, 2026 |
| Avantium N.V. | Netherlands | 0.59% | September 21, 2026 |
| Terranet Holding AB | Sweden | 0.58% | September 18, 2026 |
| Studsvik AB | Sweden | 0.56% | September 22, 2026 |
| Amoeba | France | 0.55% | September 10, 2026 |
| NSI N.V. | Netherlands | 0.50% | August 31, 2026 |
| Signify N.V. | Netherlands | 0.50% | September 22, 2026 |
Get the moves on Citadel Securities (Europe) Limited by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Issuer | Market | % of capital | End of publication |
|---|---|---|---|---|
| February 6, 2025 | Median Technologies | France | 0.62% | March 31, 2025 |
| January 29, 2025 | Vivoryon Therapeutics N.V. | Netherlands | 0.57% | |
| January 27, 2025 | Kalray | France | 0.47% | January 29, 2025 |
| January 24, 2025 | Vivoryon Therapeutics N.V. | Netherlands | 0.62% | |
| January 23, 2025 | Vivoryon Therapeutics N.V. | Netherlands | 0.71% | |
| January 22, 2025 | Vivoryon Therapeutics N.V. | Netherlands | 0.67% | |
| January 15, 2025 | Kalray | France | 0.69% | January 29, 2025 |
| January 14, 2025 | Vivoryon Therapeutics N.V. | Netherlands | 0.79% | |
| January 14, 2025 | Kalray | France | 0.71% | January 29, 2025 |
| January 13, 2025 | Kalray | France | 0.69% | January 29, 2025 |
| January 13, 2025 | Vivoryon Therapeutics N.V. | Netherlands | 0.60% | |
| January 10, 2025 | Vivoryon Therapeutics N.V. | Netherlands | 0.57% | |
| January 9, 2025 | Adocia | France | 0.48% | January 13, 2025 |
| January 8, 2025 | Solutions 30 SE | France | 0.62% | February 20, 2025 |
| January 6, 2025 | Kalray | France | 0.80% | January 29, 2025 |
| January 6, 2025 | Solutions 30 SE | France | 0.58% | February 20, 2025 |
| January 2, 2025 | Kalray | France | 0.62% | January 29, 2025 |
| January 2, 2025 | Adocia | France | 0.58% | January 13, 2025 |
| January 2, 2025 | Vivoryon Therapeutics N.V. | Netherlands | 0.47% | |
| December 30, 2024 | Adocia | France | 0.67% | January 13, 2025 |
| December 30, 2024 | Vivoryon Therapeutics N.V. | Netherlands | 0.58% | |
| December 27, 2024 | Kalray | France | 0.87% | January 29, 2025 |
| December 27, 2024 | Vivoryon Therapeutics N.V. | Netherlands | 0.61% | |
| December 20, 2024 | Adocia | France | 0.70% | January 13, 2025 |
| December 19, 2024 | Kalray | France | 0.92% | January 29, 2025 |
| December 19, 2024 | Adocia | France | 0.63% | January 13, 2025 |
| December 12, 2024 | Kalray | France | 0.80% | January 29, 2025 |
| December 11, 2024 | Ebusco Holding N.V. | Netherlands | 0.48% | |
| December 10, 2024 | Adocia | France | 0.71% | January 13, 2025 |
| December 9, 2024 | Vivoryon Therapeutics N.V. | Netherlands | 0.79% | |
| December 9, 2024 | Kalray | France | 0.72% | January 29, 2025 |
| December 9, 2024 | Solutions 30 SE | France | 0.61% | February 20, 2025 |
| December 6, 2024 | Adocia | France | 0.69% | January 13, 2025 |
| December 6, 2024 | Kalray | France | 0.68% | January 29, 2025 |
| December 6, 2024 | Vivoryon Therapeutics N.V. | Netherlands | 0.62% | |
| December 6, 2024 | Solutions 30 SE | France | 0.59% | February 20, 2025 |
| December 6, 2024 | Cavendish Hydrogen ASA | Norway | 0.57% | December 10, 2024 |
| December 5, 2024 | Solutions 30 SE | France | 0.60% | February 20, 2025 |
| December 4, 2024 | Adocia | France | 0.71% | January 13, 2025 |
| December 3, 2024 | Kalray | France | 0.80% | January 29, 2025 |
| December 3, 2024 | Adocia | France | 0.67% | January 13, 2025 |
| December 3, 2024 | Ebusco Holding N.V. | Netherlands | 0.51% | |
| December 2, 2024 | Ebusco Holding N.V. | Netherlands | 0.70% | |
| December 2, 2024 | Kalray | France | 0.61% | January 29, 2025 |
| December 2, 2024 | Vivoryon Therapeutics N.V. | Netherlands | 0.54% | |
| November 29, 2024 | Ebusco Holding N.V. | Netherlands | 0.61% | |
| November 28, 2024 | Kalray | France | 0.54% | January 29, 2025 |
| November 27, 2024 | Adocia | France | 0.73% | January 13, 2025 |
| November 22, 2024 | Ebusco Holding N.V. | Netherlands | 0.00% | |
| November 21, 2024 | Ebusco Holding N.V. | Netherlands | 0.51% |
Download 930 filings as CSV Columns: Date, Issuer, Market, Disclosed position, Unit, End date. The other formats
The funds short on the same companies
- GSA Capital Partners LLP 2 companies in common
- AQR Capital Management, LLC 1 company in common
- Citadel Advisors LLC 1 company in common
- Eleva Capital SAS 1 company in common
- Farallon Capital Management, L.L.C. 1 company in common
- Numeric Investors LLC 1 company in common
- Origo Fonder AB 1 company in common
- PDT Partners, LLC 1 company in common
- SIH Partners LLLP 1 company in common
- Squarepoint Ops LLC 1 company in common
- Two Sigma Investments, LP 1 company in common
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Citadel Securities (Europe) Limited, data as at September 24, 2026, https://www.quivad.com/detenteur/citadel-securities-europe-limited?page=12